OCULIS HOLDING AG (OCS) Fundamental Analysis & Valuation

NASDAQ:OCS • CH1242303498

Current stock price

27.41 USD
-0.07 (-0.25%)
Last:

This OCS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. OCS Profitability Analysis

1.1 Basic Checks

  • OCS had negative earnings in the past year.
  • In the past year OCS has reported a negative cash flow from operations.
  • OCS had negative earnings in each of the past 5 years.
  • In the past 5 years OCS always reported negative operating cash flow.
OCS Yearly Net Income VS EBIT VS OCF VS FCFOCS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 -20M -40M -60M -80M

1.2 Ratios

  • The Return On Assets of OCS (-41.94%) is worse than 60.21% of its industry peers.
  • With a Return On Equity value of -50.47%, OCS perfoms like the industry average, outperforming 51.31% of the companies in the same industry.
Industry RankSector Rank
ROA -41.94%
ROE -50.47%
ROIC N/A
ROA(3y)-63.62%
ROA(5y)-65.45%
ROE(3y)-87.37%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OCS Yearly ROA, ROE, ROICOCS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 0 -50 -100

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for OCS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OCS Yearly Profit, Operating, Gross MarginsOCS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. OCS Health Analysis

2.1 Basic Checks

  • OCS has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, OCS has more shares outstanding
  • Compared to 1 year ago, OCS has about the same debt to assets ratio.
OCS Yearly Shares OutstandingOCS Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
OCS Yearly Total Debt VS Total AssetsOCS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

2.2 Solvency

  • OCS has an Altman-Z score of 17.50. This indicates that OCS is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 17.50, OCS belongs to the best of the industry, outperforming 87.43% of the companies in the same industry.
  • A Debt/Equity ratio of 0.01 indicates that OCS is not too dependend on debt financing.
  • OCS's Debt to Equity ratio of 0.01 is in line compared to the rest of the industry. OCS outperforms 54.97% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 17.5
ROIC/WACCN/A
WACCN/A
OCS Yearly LT Debt VS Equity VS FCFOCS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 50M -50M 100M 150M

2.3 Liquidity

  • A Current Ratio of 5.96 indicates that OCS has no problem at all paying its short term obligations.
  • With a decent Current ratio value of 5.96, OCS is doing good in the industry, outperforming 70.16% of the companies in the same industry.
  • OCS has a Quick Ratio of 5.96. This indicates that OCS is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Quick ratio value of 5.96, OCS is doing good in the industry, outperforming 70.16% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.96
Quick Ratio 5.96
OCS Yearly Current Assets VS Current LiabilitesOCS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. OCS Growth Analysis

3.1 Past

  • OCS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.57%, which is quite good.
EPS 1Y (TTM)8.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%37.31%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%13600%

3.2 Future

  • The Earnings Per Share is expected to grow by 21.00% on average over the next years. This is a very strong growth
  • OCS is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 271.60% yearly.
EPS Next Y5.97%
EPS Next 2Y-0.83%
EPS Next 3Y10.31%
EPS Next 5Y21%
Revenue Next Year763.81%
Revenue Next 2Y607.65%
Revenue Next 3Y440.39%
Revenue Next 5Y271.6%

3.3 Evolution

OCS Yearly Revenue VS EstimatesOCS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 500M 1B 1.5B
OCS Yearly EPS VS EstimatesOCS Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 2 -2 4

More info and screens

Find the best growth stocksShow best growing peers

0

4. OCS Valuation Analysis

4.1 Price/Earnings Ratio

  • OCS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year OCS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OCS Price Earnings VS Forward Price EarningsOCS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OCS Per share dataOCS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-0.83%
EPS Next 3Y10.31%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. OCS Dividend Analysis

5.1 Amount

  • OCS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

OCS Fundamentals: All Metrics, Ratios and Statistics

OCULIS HOLDING AG

NASDAQ:OCS (5/1/2026, 2:53:34 PM)

27.41

-0.07 (-0.25%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Industry StrengthN/A
Industry GrowthN/A
Earnings (Last)03-03
Earnings (Next)05-07
Inst Owners40.07%
Inst Owner Change0.06%
Ins Owners4.27%
Ins Owner ChangeN/A
Market Cap1.40B
Revenue(TTM)N/A
Net Income(TTM)-98.96M
Analysts86.67
Price Target48.14 (75.63%)
Short Float %1.01%
Short Ratio1.23
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.43%
Min EPS beat(2)1.62%
Max EPS beat(2)25.25%
EPS beat(4)2
Avg EPS beat(4)-8.46%
Min EPS beat(4)-56.2%
Max EPS beat(4)25.25%
EPS beat(8)3
Avg EPS beat(8)-15.67%
EPS beat(12)4
Avg EPS beat(12)-14.6%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)117.55%
Min Revenue beat(2)24.83%
Max Revenue beat(2)210.28%
Revenue beat(4)4
Avg Revenue beat(4)75.15%
Min Revenue beat(4)24.83%
Max Revenue beat(4)210.28%
Revenue beat(8)4
Avg Revenue beat(8)21.28%
Revenue beat(12)7
Avg Revenue beat(12)40.6%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)7.27%
PT rev (3m)7.27%
EPS NQ rev (1m)-1.77%
EPS NQ rev (3m)12.25%
EPS NY rev (1m)4.6%
EPS NY rev (3m)4.6%
Revenue NQ rev (1m)7.55%
Revenue NQ rev (3m)5.52%
Revenue NY rev (1m)0%
Revenue NY rev (3m)9.19%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 5.6
P/tB 6
EV/EBITDA N/A
EPS(TTM)-2.44
EYN/A
EPS(NY)-2.3
Fwd EYN/A
FCF(TTM)-1.69
FCFYN/A
OCF(TTM)-1.66
OCFYN/A
SpS0
BVpS4.9
TBVpS4.57
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -41.94%
ROE -50.47%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-63.62%
ROA(5y)-65.45%
ROE(3y)-87.37%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 254.21%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.96
Quick Ratio 5.96
Altman-Z 17.5
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)109.2%
Cap/Depr(5y)304.68%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)8.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%37.31%
EPS Next Y5.97%
EPS Next 2Y-0.83%
EPS Next 3Y10.31%
EPS Next 5Y21%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%13600%
Revenue Next Year763.81%
Revenue Next 2Y607.65%
Revenue Next 3Y440.39%
Revenue Next 5Y271.6%
EBIT growth 1Y-11.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-25.53%
EBIT Next 3Y-13.4%
EBIT Next 5Y44.64%
FCF growth 1Y-37.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-35.54%
OCF growth 3YN/A
OCF growth 5YN/A

OCULIS HOLDING AG / OCS Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for OCULIS HOLDING AG?

ChartMill assigns a fundamental rating of 2 / 10 to OCS.


Can you provide the valuation status for OCULIS HOLDING AG?

ChartMill assigns a valuation rating of 0 / 10 to OCULIS HOLDING AG (OCS). This can be considered as Overvalued.


What is the profitability of OCS stock?

OCULIS HOLDING AG (OCS) has a profitability rating of 0 / 10.


How financially healthy is OCULIS HOLDING AG?

The financial health rating of OCULIS HOLDING AG (OCS) is 5 / 10.